Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats
Authors:
- Ashfaq ShuaibASAshfaq Shuaib
- 1 June 2007
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 205 (2) , 563-568
Abstract
No abstract availableKeywords
Funding Information
- Heart and Stroke Foundation of Canada
- Canadian Institutes of Health Research
This publication has 24 references indexed in Scilit:
- The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen SpeciesThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte AggregatesCirculation, 2005
- Acetylsalicylic acid reduces perfusion deficit in ischemic injured brain in ratsNeuroReport, 2003
- Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination TherapyJournal of Cerebral Blood Flow & Metabolism, 2002
- Patency of Cerebral Microvessels after Focal Embolic Stroke in the RatJournal of Cerebral Blood Flow & Metabolism, 2001
- Inhibitory Effect of Dipyridamole and its Derivatives on Lipid Peroxidation in MitochondriaFree Radical Biology and Medicine, 1997
- A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamoleFree Radical Biology and Medicine, 1995
- Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxideEuropean Journal of Pharmacology, 1991
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMThe Lancet, 1987
- Dipyridamole and Aspirin in Relation to Platelet Aggregation and Vessel Wall Prostaglandin GenerationJournal of Cardiovascular Pharmacology, 1982